A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery
NCT ID: NCT00519961
Last Updated: 2011-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1800 participants
INTERVENTIONAL
2007-02-28
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of B-type Natriuretic Peptide With N-terminal Pro B-type Natriuretic Peptide in Perioperative Risk Assessment
NCT05352698
Use of NT-proBNP Testing to Guide Heart Failure Therapy in the Outpatient Setting.
NCT00351390
A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH)
NCT04193046
Prognostic Risk of Patients With Essential Hypertension for Cardiovascular Events (PROSPECT)
NCT03708601
Prospective Observational Study of the Sacubitril-Valsartan Treatment Effectiveness.
NCT04133428
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Elecsys®proBNP
B
Elecsys®proBNP
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Elecsys®proBNP
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with peripheral vascular atherosclerosis, scheduled for vascular surgery
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hoffmann-La Roche
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wilma Verhagen-Kamerbeek
Role: STUDY_DIRECTOR
Roche Diagnostics GmbH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dublin, , Ireland
Rotterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DECREASE-VI
Identifier Type: -
Identifier Source: secondary_id
RD000485
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.